BioMarin Submits Kuvan For Phenylketonuria
Firm is asking FDA for a priority review, which would potentially allow for a late 2007 launch of the orphan drug.
Firm is asking FDA for a priority review, which would potentially allow for a late 2007 launch of the orphan drug.